Utilize Optomed Avenue in screening

for diabetic retinopathy



Diabetes is a global pandemic and diabetic retinopathy is the most common cause of vision loss among working age people. There are millions of people at risk of developing this condition and becoming visually impaired. Start

saving sight today with the

Optomed Avenue system!

Visual impairment could be

prevented with early screening

for diabetic retinopathy.


Beat the challenge – let Optomed Avenue be road to care for

Your patients. 

Beat the


Some may call this artificial intelligence, but we prefer to think it also possesses genuine intelligence. Optomed Avenue analyzes retinal images automatically

and immediately gives an easy-to-understand result showing whether

the patient has an elevated risk of diabetic retinopathy.

Intelligence at
your service
Cost is no longer a barrier for diabetic retinopathy screening

How can I buy it?

Optomed Avenue is now available in Finland and later 2017 in selected markets.  Please leave your contact information to be contacted by the reseller.